SVRA (Savara) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SVRA Savara Inc SVRA
19 GF Score
Price $5.74
! 3 Warning Signs
View Full Analysis

What is Savara FFO?

FFO (Funds from operations) only applies to REITs.

SVRA
19GF Score
Savara Inc SVRA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Savara Business Description

Other Exchanges YB4P:Germany
Address 1717 Langhorne Newtown Road, Suite 300, One Summit Square, Langhorne, PA, USA, 19047
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
19GF Score

Get the complete analysis for SVRA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.74
Price